[{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 72)","specimen_descriptor_fill":"Pediatric Primary Tumors","box_sample_count":63,"Gene_Ensembl_ID":"ENSG00000273032","Gene_symbol":"DGCR5","PMTL":"","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.67,"TPM_sd":1.44,"TPM_min":0.01,"TPM_25th_percentile":0.5,"TPM_median":1.04,"TPM_75th_percentile":2.76,"TPM_max":6.22},{"x_label":"Diffuse midline glioma  (Dataset = PBTA, Specimen = Pediatric Primary and Relapse Tumors, N = 72)","specimen_descriptor_fill":"Pediatric Relapse Tumors","box_sample_count":9,"Gene_Ensembl_ID":"ENSG00000273032","Gene_symbol":"DGCR5","PMTL":"","Dataset":"PBTA","Disease":"Diffuse midline glioma","GTEx_tissue_subgroup":"","EFO":"EFO_1000026","MONDO":"MONDO_0006033","GTEx_tissue_subgroup_UBERON":"","TPM_mean":1.34,"TPM_sd":1.49,"TPM_min":0.1,"TPM_25th_percentile":0.18,"TPM_median":1.01,"TPM_75th_percentile":1.22,"TPM_max":3.93},{"x_label":"Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 165)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":152,"Gene_Ensembl_ID":"ENSG00000273032","Gene_symbol":"DGCR5","PMTL":"","Dataset":"TCGA","Disease":"Glioblastoma Multiforme","GTEx_tissue_subgroup":"","EFO":"EFO_0000519","MONDO":"MONDO_0018177","GTEx_tissue_subgroup_UBERON":"","TPM_mean":2.55,"TPM_sd":1.73,"TPM_min":0.15,"TPM_25th_percentile":1.33,"TPM_median":2.24,"TPM_75th_percentile":3.41,"TPM_max":9.17},{"x_label":"Glioblastoma Multiforme  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 165)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":13,"Gene_Ensembl_ID":"ENSG00000273032","Gene_symbol":"DGCR5","PMTL":"","Dataset":"TCGA","Disease":"Glioblastoma Multiforme","GTEx_tissue_subgroup":"","EFO":"EFO_0000519","MONDO":"MONDO_0018177","GTEx_tissue_subgroup_UBERON":"","TPM_mean":3.46,"TPM_sd":3.78,"TPM_min":0.52,"TPM_25th_percentile":1.85,"TPM_median":2.45,"TPM_75th_percentile":3.18,"TPM_max":15.55},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 521)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":507,"Gene_Ensembl_ID":"ENSG00000273032","Gene_symbol":"DGCR5","PMTL":"","Dataset":"TCGA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":6.59,"TPM_sd":5.65,"TPM_min":0.2,"TPM_25th_percentile":3.43,"TPM_median":5.39,"TPM_75th_percentile":8.5,"TPM_max":89.07},{"x_label":"Low-grade glioma/astrocytoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 521)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":14,"Gene_Ensembl_ID":"ENSG00000273032","Gene_symbol":"DGCR5","PMTL":"","Dataset":"TCGA","Disease":"Low-grade glioma/astrocytoma","GTEx_tissue_subgroup":"","EFO":"MONDO_0016685","MONDO":"MONDO_0016685","GTEx_tissue_subgroup_UBERON":"","TPM_mean":5.66,"TPM_sd":5.09,"TPM_min":0.4,"TPM_25th_percentile":2.05,"TPM_median":4.61,"TPM_75th_percentile":5.97,"TPM_max":17.75},{"x_label":"Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 378)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":373,"Gene_Ensembl_ID":"ENSG00000273032","Gene_symbol":"DGCR5","PMTL":"","Dataset":"TCGA","Disease":"Ovarian Serous Cystadenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000043","MONDO":"MONDO_0006046","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.41,"TPM_sd":0.59,"TPM_min":0.01,"TPM_25th_percentile":0.1,"TPM_median":0.22,"TPM_75th_percentile":0.46,"TPM_max":4.54},{"x_label":"Ovarian Serous Cystadenocarcinoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 378)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":5,"Gene_Ensembl_ID":"ENSG00000273032","Gene_symbol":"DGCR5","PMTL":"","Dataset":"TCGA","Disease":"Ovarian Serous Cystadenocarcinoma","GTEx_tissue_subgroup":"","EFO":"EFO_1000043","MONDO":"MONDO_0006046","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.56,"TPM_sd":0.47,"TPM_min":0,"TPM_25th_percentile":0.26,"TPM_median":0.57,"TPM_75th_percentile":0.71,"TPM_max":1.24},{"x_label":"Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 261)","specimen_descriptor_fill":"TCGA Primary Tumors","box_sample_count":258,"Gene_Ensembl_ID":"ENSG00000273032","Gene_symbol":"DGCR5","PMTL":"","Dataset":"TCGA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.51,"TPM_sd":0.87,"TPM_min":0,"TPM_25th_percentile":0.05,"TPM_median":0.13,"TPM_75th_percentile":0.58,"TPM_max":5.12},{"x_label":"Sarcoma  (Dataset = TCGA, Specimen = TCGA Primary and Relapse Tumors, N = 261)","specimen_descriptor_fill":"TCGA Relapse Tumors","box_sample_count":3,"Gene_Ensembl_ID":"ENSG00000273032","Gene_symbol":"DGCR5","PMTL":"","Dataset":"TCGA","Disease":"Sarcoma","GTEx_tissue_subgroup":"","EFO":"EFO_0000691","MONDO":"MONDO_0005089","GTEx_tissue_subgroup_UBERON":"","TPM_mean":0.52,"TPM_sd":0.11,"TPM_min":0.44,"TPM_25th_percentile":0.45,"TPM_median":0.47,"TPM_75th_percentile":0.56,"TPM_max":0.65}]